Discovery of Potent Isoquinolinequinone N -Oxides to Overcome Cancer Multidrug Resistance
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00705 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Ryan D Kruschel und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Analytical and Biological Chemistry Research Facility, University College Cork, Cork T12 K8AF, Ireland. Hauptthemen laut MEDLINE: Antineoplastic Agents, Cell Proliferation, Drug Resistance, Multiple, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Irish Research Council, European Commission, European Cooperation in Science and Technology.
Abstract (Originalsprache)
Multidrug resistance (MDR) of human tumors has resulted in an immediate need to develop appropriate new drugs. This work outlines the development of 20 potent IQQ N-oxide derivatives in two isomeric families, both exhibiting nanomolar GI50 against human tumor cell lines. Preliminary NCI-60 tumor screening sees the C(6) isomers achieve a mean GI50 > 2 times lower than the corresponding C(7) isomers. MDR evaluation of nine selected compounds reveals that each presents lower GI50 concentrations in two MDR tumor cell lines. Four of the series display nanomolar GI50 values against MDR cells, having selectivity ratios up to 2.7 versus the sensitive (parental) cells. The most potent compound 25 inhibits the activity of drug efflux pumps in MDR cells, causes significant ROS accumulation, and potently inhibits cell proliferation, causing alterations in the cell cycle profile. Our findings are confirmed by 3D spheroid models, providing new candidates for studies against MDR cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry, Analytical and Biological Chemistry Research Facility, University College Cork, Cork T12 K8AF, Ireland.
- i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto Portugal.
- Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology, University of Porto, 4200-135 Porto Portugal.
- FFUP-Faculty of Pharmacy of the University of Porto, 4050-313 Porto Portugal.
ORCID-Profile: Ryan D Kruschel, Mélanie A G Barbosa, Maria João Almeida, Cristina P R Xavier, M Helena Vasconcelos, Florence O McCarthy
Förderung
- Irish Research Council
- European Commission
- European Cooperation in Science and Technology
- Comissão de Coordenação e Desenvolvimento Regional do Norte
- Ministério da Educação e Ciência
Zitieren
APA
Kruschel, R. D., Barbosa, M. A. G., Almeida, M. J., Xavier, C. P. R., Vasconcelos, M. H., & McCarthy, F. O. (2024). Discovery of Potent Isoquinolinequinone N -Oxides to Overcome Cancer Multidrug Resistance. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00705
Vancouver
Kruschel RD, Barbosa MAG, Almeida MJ, Xavier CPR, Vasconcelos MH, McCarthy FO. Discovery of Potent Isoquinolinequinone N -Oxides to Overcome Cancer Multidrug Resistance. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00705
BibTeX
@article{Kruschel2024,
author = {Kruschel, Ryan D and Barbosa, Mélanie A G and Almeida, Maria João and Xavier, Cristina P R and Vasconcelos, M Helena and McCarthy, Florence O},
title = {Discovery of Potent Isoquinolinequinone N -Oxides to Overcome Cancer Multidrug Resistance},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00705}
}
EUVIMED